Liver Carcinoma Clinical Trials

28 clinical trials for Liver Carcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Vanguard Study: Testing a New Way to Screen for Cancer — RECRUITING · NA
• the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma — RECRUITING · NA
• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling — RECRUITING
• Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy — RECRUITING · NA
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• CIRSE Registry for SIR-Spheres Therapy — COMPLETED
• Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery — SUSPENDED
• Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis — COMPLETED · PHASE4
• Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma — ACTIVE_NOT_RECRUITING
• Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence — COMPLETED
• Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device — COMPLETED · NA
• Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers — OTHER
• A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma — OTHER · PHASE1
• Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation — COMPLETED · NA
• Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma — COMPLETED · NA
• Liver Transplantation for Unresectable GIST Liver Metastases — OTHER · NA
• Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) — OTHER · NA
• AFP Model and Liver Transplantation. — COMPLETED
• Combined HCC-MFCCC — COMPLETED
• SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma — COMPLETED · PHASE3
• Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma — TERMINATED · PHASE1
• Permission to Collect Blood Over Time for Research — TERMINATED
• Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation — WITHDRAWN · NA
• Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial — OTHER · PHASE2
• De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma — COMPLETED · PHASE2
• Hepatocellular Carcinoma Treated With Iodine-125 Implantation — COMPLETED · PHASE3
• The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma — OTHER
• Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma — TERMINATED · PHASE1

Refine this search